#Market News  45 PM / in 10 minutes BRIEF-Juno Therapeutics Says If Deal Terminated By Co Or Celgene, Fee Of $300 Mln May Be Payable By Co To Celgene Reuters Staff 1 Min Read 
Jan 22 (Reuters) - Celgene Corp: 
* JUNO THERAPEUTICS SAYS IF DEAL TERMINATED BY CO OR CELGENE UPON SPECIFIED CONDITIONS, FEE OF $300 MILLION MAY BE PAYABLE BY CO TO CELGENE - SEC FILING 
* JUNO THERAPEUTICS SAYS DEAL AGREEMENT PROVIDES CELGENE TO HAVE TO PAY CO REVERSE TERMINATION FEE OF $600 MILLION IF DEAL TERMINATED UNDER SOME CONDITIONS Source text: ( bit.ly/2n0Tiwe ) Further company coverage: